Carmichael Hill & Associates, Inc. Ark Genomic Revolution ETF (De Transaction History
Carmichael Hill & Associates, Inc.
- $279 Million
- Q3 2024
A detailed history of Carmichael Hill & Associates, Inc. transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Carmichael Hill & Associates, Inc. holds 100 shares of ARKG stock, worth $2,942. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100
Previous 100
-0.0%
Holding current value
$2,942
Previous $2,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ARKG
# of Institutions
281Shares Held
24.1MCall Options Held
3.02MPut Options Held
2.58M-
Goldman Sachs Group Inc New York, NY3.63MShares$107 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.79MShares$82.1 Million0.01% of portfolio
-
Bank Of America Corp Charlotte, NC2.78MShares$81.9 Million0.01% of portfolio
-
Citigroup Inc1.66MShares$48.7 Million0.02% of portfolio
-
Morgan Stanley New York, NY1.41MShares$41.6 Million0.0% of portfolio